NCT00005910
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +16 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
Clinical trial condition
Adenoma
Explore clinical trials studying Adenoma. Study availability and eligibility vary by location and protocol.
597 public trials
137 recruiting studies
Adenoma trial results
NCT00001814
- Conditions
- Adenoma, Adenoma, Oxyphilic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00481299
- Conditions
- Adenoma, Brain Diseases, Central Nervous System Diseases, +22 more
- Locations
-
- Clementino Fraga Filho University Hospital Rio de Janeiro, Brazil
NCT00386815
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyōgo, Japan
NCT00190762
- Conditions
- Adenoma, Mesothelioma, Neoplasms, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9:00 AM - 5:00 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician Ottawa, Ontario, Canada
NCT00061477
- Conditions
- Adenoma, Mesothelioma, Neoplasms, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States
Active, Not Recruiting
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
NCT06097728
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Research Site Santa Rosa, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Jacksonville, Florida, United States
- Research Site Atlanta, Georgia, United States
Active, Not Recruiting
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
NCT01843374
- Conditions
- Adenoma, Diabetes Mellitus, Insulin-Dependent, 12, Lung Diseases, +13 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site La Jolla, California, United States
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States
Active, Not Recruiting
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
NCT04577326
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Active, Not Recruiting
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
NCT02414269
- Conditions
- Adenoma, Breast Cancer, Breast Diseases, +21 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Consent and Follow-Up) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Consent and Follow-Up) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (Consent and Follow-Up) Commack, New York, United States